UNSPSC 51432603: Zankiren

This classification denotes an antihypertensive agent with the molecular formula C35H55N5O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I36B16A34Q, chemically known as 4-thiazolepropanamide, n-((1s,2r,3s)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl)-alpha-(((2s)-2-(((4-methyl-1-piperazinyl)sulfonyl)methyl)-1-oxo-3-phenylpropyl)amino)-, (alphas)- but generally known as zankiren, which bears US NIH Compound Identifier 3036088.

UNSPSC 51432603 Zankiren is a Commodity code encompassing advanced life support and emergency medications supplied to state and local health care and emergency response agencies. State and local governments procure specific injectable medications—epinephrine, labetalol, adenosine, diltiazem, and similar agents—for use by fire rescue departments, emergency medical services, hospital systems, and public health programs. Issuing bodies include municipal purchasing departments on behalf of fire rescue services, state health and human services commissions managing pharmacy benefit programs, and multistate cooperative purchasing alliances coordinating procurement across member jurisdictions. The code also captures generic multi-source pharmaceuticals and over-the-counter products distributed through state and local facilities via authorized wholesale channels. Solicitations typically require vendors to maintain compliance with FDA regulations, cGMP certification, Drug Supply Chain Security Act (DSCSA) requirements, and OSHA Hazard Communication Standards. Contracts often include warranty provisions for product integrity, expiration-date guarantees (commonly nine months to one year minimum shelf life at delivery), and rapid fulfillment timelines measured in days. Small local business enterprise (SLBE) set-asides and accessibility documentation requirements appear in some municipal procurements.

Recent activity spans Florida, Texas, and Minnesota. The City of Tampa's Purchasing Department issued IFB 26P00188 for Advanced Life Support Medications to Tampa Fire Rescue with a due date of April 8, 2026 and estimated value of $40,000.00, requiring delivery within ten calendar days and renewal options through one year with two additional one-year extensions plus three 30-day unilateral extensions. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to solicit vendor capabilities for a direct-to-manufacturer prescription program outside traditional pharmacy benefit manager channels, with responses due April 3, 2026. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota and Oregon, with responses due March 26, 2026 and contract effectiveness July 1, 2026. MMCAP evaluates proposals on price competitiveness (75 percent weight), fixed pricing structure (10 percent), compliance with administrative formatting and EDI capability (10 percent), and agreement to a 3 percent administrative fee (5 percent), reserving the right to make sole, dual, or multi-awards based on therapeutic and safety considerations.